v1
Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: a Pediatric Oncology Group study.
Identifier:nobleid.org/w1/20260515/3BFCB7CD
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/3BFCB7CD)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims